Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 9/2018

01-09-2018 | Letter to the Editors

Primary progressive freezing gait with impressive response to laser light visual cueing: a video case report

Authors: Moisés León Ruiz, Miguel Á. García-Soldevilla, Esteban García-Albea Ristol

Published in: Journal of Neurology | Issue 9/2018

Login to get access

Excerpt

Dear Sirs, …
Appendix
Available only for authorised users
Literature
1.
Fasano A, Bloem BR (2013) Gait disorders. Continuum (Minneap Minn) 19:1344–1482
2.
3.
Rohani M, Kalsi-Ryan S, Lozano AM, Fasano A (2017) Spinal cord stimulation in primary progressive freezing of gait. Mov Disord 32:1336–1337CrossRefPubMed
4.
Factor SA (2008) The clinical spectrum of freezing of gait in atypical parkinsonism. Mov Disord 23:S431–S438CrossRefPubMed
5.
Fasano A, Baldari S, Di Giuda D et al (2012) Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Parkinsonism Relat Disord 18:578–584CrossRefPubMed
6.
Factor SA, Higgins DS, Qian J (2006) Primary progressive freezing gait: a syndrome with many causes. Neurology 66:411–414CrossRefPubMed
7.
Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19:871–884CrossRefPubMed
8.
9.
Jankovic J (2016) Neurological diseases and their treatment. Neurological disorders. Parkinson disease and other movement disorders. Progressive supranuclear palsy. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL (eds) Bradley’s neurology in clinical practice, vol 2, 7th edn. Elsevier Saunders, Philadelphia, pp 1439–1440
10.
Höglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864CrossRefPubMedPubMedCentral
11.
Respondek G, Kurz C, Arzberger T et al (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995–1005CrossRefPubMedPubMedCentral
12.
Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279CrossRefPubMed
13.
Donovan S, Lim C, Diaz N et al (2011) Laserlight cues for gait freezing in Parkinson’s disease: an open-label study. Parkinsonism Relat Disord 17:240–245CrossRefPubMed
14.
Velik R, Hoffmann U, Zabaleta H, Marti Masso JF, Keller T (2012) The effect of visual cues on the number and duration of freezing episodes in Parkinson’s patients. Conf Proc IEEE Eng Med Biol Soc 2012:4656–4659PubMed
15.
Marsden CD, Obeso JA (1994) The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson’s disease. Brain 117:877–897CrossRefPubMed
Metadata
Title
Primary progressive freezing gait with impressive response to laser light visual cueing: a video case report
Authors
Moisés León Ruiz
Miguel Á. García-Soldevilla
Esteban García-Albea Ristol
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 9/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8966-9

Other articles of this Issue 9/2018

Journal of Neurology 9/2018 Go to the issue

Neurological Update

The effect of fingolimod on focal and diffuse grey matter damage in active MS patients

Original Communication

Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers

Letter to the Editors

Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample Mendelian randomization study

Original Communication

The accuracy of the clinical diagnosis of Parkinson disease. The HUNT study

Journal club

New treatments in Alzheimer’s disease

Original Communication

Dysfunctional inhibitory control in Parkinson’s disease patients with levodopa-induced dyskinesias